Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript February 27, 2024 Kura Oncology, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.56. Kura Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
Related Keywords
Troy Wilson , Tom Doyle , Warren Buffett , Most Valuable Tobacco Companies , Bristol Myers Squibb , Farnesyl Transferase Inhibitor , Tyrosine Kinase , Mirati Therapeutics , Valuable Tobacco Companies , Dividend Stocks , Buy According ,
comparemela.com © 2020. All Rights Reserved.